During the past decade, Emory Children's Center conducted 37 clinical trials. In the 10-year time frame, 37 clinical trials started and 19 clinical trials were completed, i.e. on average, 51.4% percent of trials that started reached the finish line to date. In the past 5 years, 16 clinical trials started and 12 clinical trials were completed. i.e. 75% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Emory Children's Center" #1 sponsor was "Emory University" with 15 trials, followed by "National Institute of Allergy and Infectious Diseases (NIAID)" with 5 trials sponsored, "National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)" with 4 trials sponsored, "Horizon Pharma USA, Inc." with 3 trials sponsored and "BioNTech SE" with 3 trials sponsored. Other sponsors include 21 different institutions and companies that sponsored additional 26 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Emory Children's Center" #1 collaborator was "National Heart, Lung, and Blood Institute (NHLBI)" with 4 trials as a collaborator, "Boston Children's Hospital" with 2 trials as a collaborator, "Childhood Arthritis and Rheumatology Research Alliance" with 2 trials as a collaborator, "Children's Hospital of Philadelphia" with 2 trials as a collaborator and "Cystic Fibrosis Foundation" with 2 trials as a collaborator. Other collaborators include 64 different institutions and companies that were collaborators in the rest 71 trials.

According to Clinical.Site data, the most researched conditions in "Emory Children's Center" are "Cystinosis" (3 trials), "Growth Hormone Deficiency" (3 trials), "Anemia, Sickle Cell" (2 trials), "Asthma" (2 trials) and "Atypical Hemolytic Uremic Syndrome" (2 trials). Many other conditions were trialed in "Emory Children's Center" in a lesser frequency.

Most popular intervention types in "Emory Children's Center" are "Drug" (30 trials), "Other" (8 trials), "Biological" (5 trials), "Device" (4 trials) and "Dietary Supplement" (3 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (14 trials), "DCCR" (2 trials), "Methylprednisolone" (2 trials), "Placebo for DCCR" (2 trials) and "Prednisone" (2 trials). Other intervention names were less common.

The vast majority of trials in "Emory Children's Center" are 53 trials for "All" genders and 2 trials for "Female" genders.

Currently, there are NaN active trials in "Emory Children's Center". 1 are not yet recruiting, 14 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 30 completed trials in Emory Children's Center, undefined suspended trials, and 6 terminated clinical trials to date.

Out of the total trials that were conducted in Emory Children's Center, 5 "Phase 1" clinical trials were conducted, 18 "Phase 2" clinical trials and 16 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 9 trials that are defined as “Not Applicable".